Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

Your video will begin in 10
Skip ad (5)
The new system to launch an online business

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Added by admin
23 Views
Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
https://www.youtube.com/channel/UCrM7B7SL_g1edFOnmj-SDKg
 
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
https://www.youtube.com/playlist?list=PLfAX25ZLrPGTygCwn55voYZ_LYyKjxokJ
 
Get the latest in tech from Silicon Valley and around the world here:
https://www.bloomberg.com/technology
Connect with us on...
X: https://twitter.com/technology
Facebook: https://www.facebook.com/BloombergTechnology
Instagram: https://www.instagram.com/bloombergbusiness/
 
Follow Ed Ludlow on X here: https://twitter.com/EdLudlow
Follow Caroline Hyde on X here: https://twitter.com/CarolineHydeTV
 
Listen to the daily Bloomberg Technology podcast here:
https://www.bloomberg.com/podcasts/series/bloomberg-technology
 
More from Bloomberg Business
Connect with us on...
X: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/
LinkedIn: https://www.linkedin.com/company/bloomberg-news/
TikTok: https://www.tiktok.com/@bloombergbusiness
Category
Artificial Intelligence
Tags
Apple Inc., Artificial Intelligence, Caroline Hyde

Post your comment

Comments

Be the first to comment